Related references
Note: Only part of the references are listed.Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy
Swati Bhattacharyya et al.
MATRIX BIOLOGY (2011)
Inhibition of Endostatin/Collagen XVIII Deteriorates Left Ventricular Remodeling and Heart Failure in Rat Myocardial Infarction Model
Kazuya Isobe et al.
CIRCULATION JOURNAL (2010)
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Angelica M. Santos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Transforming growth factor β as a therapeutic target in systemic sclerosis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis
A. G. Richter et al.
THORAX (2009)
Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin
Bi Hu et al.
ACTA PHARMACOLOGICA SINICA (2008)
Research advances of endostatin and its short internal fragments
Huan-Li Xu et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
Hubing Shi et al.
BLOOD (2007)
Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model
K. Tanabe et al.
KIDNEY INTERNATIONAL (2007)
Gene expression profiling of familial and sporadic interstitial pneumonia
Ivana V. Yang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity
RM Tjin et al.
CANCER RESEARCH (2005)
Classification Analysis of the Transcriptosome of Nonlesional Cultured Dermal Fibroblasts From Systemic Sclerosis Patients With Early Disease
Filemon K. Tan et al.
ARTHRITIS AND RHEUMATISM (2005)
Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition
JM Pilewski et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis
M Sumi et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2005)
Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins
A Sudhakar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo
MG Cattaneo et al.
EXPERIMENTAL CELL RESEARCH (2003)
Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1
YM Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cell surface glypicans are low-affinity endostatin receptors
SA Karumanchi et al.
MOLECULAR CELL (2001)
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
M Selman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Fibrosis and angiogenesis
R Kalluri et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2000)
Secreted cathepsin L generates endostatin from collagen XVIII
U Felbor et al.
EMBO JOURNAL (2000)